Articles tagged "Kidney"

2020 American Transplant Congress
Outcomes of Kidney Donors with Impaired Fasting Glucose and Diabetes
S. Hebert, D. T. Nguyen, E. A. Graviss, H. E. Adrogue, A. Gaber, A. Matas, H. Ibrahim
Houston Methodist Hospital, Houston, TX
*Purpose: Many kidney donor candidates with impaired fasting glucose (IFG) and all candidates with diabetes (DM) are excluded from donation. The diagnostic thresholds for IFG…
2020 American Transplant Congress
A Single Nucleotide Polymorphism of Tweak Predicts Arterio- and Arteriolohyalinosis in Kidney Transplants and is Associated with Allograft Survival
A. Karolin¹, D. Thottan¹, J. Zinsli¹, S. Rudloff¹, U. Huynh-Do¹, V. Banz², T. Berney³, M. Pascual⁴, T. Müller⁵, P. d’Amico⁶, I. Binet⁷, D. Sidler¹
¹Nephrology and Hypertension, University Bern, Bern, Switzerland, ²University Bern, Bern, Switzerland, ³University Hospital Genevia, Genevia, Switzerland, ⁴University Hospital Lausanne, Lausanne, Switzerland, ⁵University Hospital Zurich, Zurich, Switzerland, ⁶Hospital St.Gallen, St.Gallen, Switzerland, ⁷University Hospital Basel, Basel, Switzerland
*Purpose: We have recently demonstrated that the TNF superfamily member is critical for the pathogenesis of Calcineurin Inhibitor Toxicity (CNT). CNT is a common side…
2020 American Transplant Congress
Has Every Possible Life Been Saved?: Rummaging Through the Discard Heap
A. L. Friedman, E. Marquez
LiveOnNY, NY, NY
*Purpose: To determine the reasons that deceased donor organs were allocated but not transplanted (TXP) in a large organ procurement organization (OPO).*Methods: All organs allocated…
2020 American Transplant Congress
Implicit Bias in Recipient Selection
Y. Sweidan¹, C. Mayuga¹, B. Daly¹, K. Chavin², T. Srinivas¹, A. Padiyar¹
¹Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, ²Surgery, University Hospitals Cleveland Medical Center, Cleveland, OH
*Purpose: The decision to place or exclude a candidate from the waitlist is not exclusively based on medical criteria. Scant literature exists regarding the intergroup…
2020 American Transplant Congress
Decision-Making, Motivations and the Donation Experience among HLA-Identical Living Kidney Donors at UCLA – A Qualitative Study
E. L. Wood¹, S. George², N. Kogut¹, E. Lum³, J. Veale¹
¹Urology, UCLA, Los Angeles, CA, ²Fielding School of Public Health, UCLA, Los Angeles, CA, ³Medicine, Nephrology, UCLA, Los Angeles, CA
*Purpose: Studies on motivations and decision-making processes of living donors have previously identified recipient relationship, fear of loss and altruism as important modifying factors of…
2020 American Transplant Congress
Evaluation of Pretransplant Serologies and Vaccination Rates in Kidney Transplant Candidates
S. Schneider, C. Truax, A. Carlson, B. Clark, B. Sirandas, L. Smith
Department of Pharmacy Services, University of Utah Health, Salt Lake City, UT
*Purpose: Assessing serologic status presents opportunities to provide live vaccinations to solid organ transplant (SOT) candidates. This is especially important given the increased risk of…
2020 American Transplant Congress
High Volume, Highly Efficient, Outcome- Centric KPD Program: A Single Center Experience with Direct Exchange Based Strategies
K. Al Meshari, D. Broering, I. Alahmadi, S. Raza, T. Ali, A. Alabbassi, H. Alahdal, F. Alzayer
King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
*Purpose: We report our three and a half year experience with direct exchange (loop) based strategy single center KPD program.*Methods: 1. Inclusion of HLA and…
2020 American Transplant Congress
Hepatitis C Antibody Seroconversion in Kidney Transplant Patients from HCV Antibody Positive/NAT Negative Donors Does Not Deteriorate Renal Allograft Outcome
R. Rattanavich, M. De Vera, T. Hoang, R. Villicana
Loma Linda University, Transplant Institute, San Bernadino, CA
*Purpose: Prior studies have shown that almost 50% of kidney transplant patients from hepatitis C Ab+/NAT - donors have seroconverted but its impact on renal…
2020 American Transplant Congress
Analysis of Rejection, Rejection Therapy and Renal Function in the BEST Trial
H. Kuzaro¹, A. R. Shields², A. Wiseman³, S. Tremblay¹, A. Christianson¹, D. Kaufman⁴, J. Leone⁵, A. Matas⁶, P. West-Thielke⁷, R. R. Alloway¹, E. S. Woodle¹
¹U Cincinnati, Cincinnati, OH, ²The Christ Hospital, Cincinnati, OH, ³U Colorado, Denver, CO, ⁴U Wisconsin, Madison, WI, ⁵Tampa General, Tampa, FL, ⁶U Minnesota, Minneapolis, MN, ⁷UIC, Chicago, IL
*Purpose: The BEST Trial (Belatacept-based Early Steroid Withdrawal) compared two belatacept (BELA)-based early corticosteroid withdrawal (ESW) regimens and alemtuzumab (ALEM) or rabbit antithymocyte globulin (rATG)…
2020 American Transplant Congress
Establishment of a National Kidney Exchange Program in Mexico: Pro-Renal
A. Cicero¹, L. Basagoitia², E. F. Velez³, A. Dib-Kuri⁴, A. E. Roth⁵, M. A. Rees⁶
¹Transplant Surgery, ABC Medical Center, Mexico City, Mexico, ²Transplant Nephrology, Centro Mexicano Pro-Donación Renal, A.C., Mexico City, Mexico, ³Medical Director, Centro Mexicano Pro-Donación Renal, A.C., Mexico City, Mexico, ⁴Director, Centro Mexicano Pro-Donación Renal, A.C., Mexico City, Mexico, ⁵Department of Economics, Stanford University, Stanford, CA, ⁶Transplant Surgery, University of Toledo Medical Center, Toledo, OH
*Purpose: Expose the need of an effective kidney paired exchange program in Mexico*Methods: Describe how Pro-Renal works. Expose weaknesses of Mexican Health System. Compare our…